SUMMARY Administration of pentagastrin in depot form to 20 pregnant bitches produced pyloric hypertrophy in about 28 % and gastroduodenal ulceration in about 16 % of their pups. The two lesions were not necessarily found in the same individuals. Histological appearances of the pylorus in affected pups closely resembled those of human infantile pyloric stenosis.
Attempts to reproduce infantile hypertrophic pyloric stenosis in experimental animals have mostly been unsuccessful. An exception was an experiment in which foreign bodies were sutured into the fundus of rabbits' stomachs, and hypertrophy of the pylorus followed as a 'compensatory mechanism' (Heinisch, 1967) . This paper reports a method in which administration of Pentagastrin to pregnant bitches has produced typical pyloric tumours in some of their offspring.
Methods

PENTAGASTRIN PREPARATIONS
Two depot forms of pentagastrin were prepared. In one, pure pentagastrin powder was suspended under aseptic conditions in an 8 % or 10 % mixture of beeswax in arachis oil, which had been previously sterilized in a hot air oven and cooled to about 60°C. The concentration of the final preparation was 8 mg pentagastrin in 1 ml. The second preparation used a base of 0-5 % phenol and 16 % gelatin, which had been sterilized by autoclaving. Pentagastrin was again added, after cooling, in a concentration of 8 mg per ml. The dogs used were a heterogeneous group of mongrels and pure breeds. They were divided into four groups as follows: Group 1 Fourteen bitches were given prenatal injections of 2-4 mg of one or other pentagastrin preparation, and in one case 20 mg, twice daily for varying periods from one to 85 days before term. Group 2 Eight bitches were similarly treated for five to 49 days, and further injections were given to their offspring at birth. The dosage used for the pups was in the range of 0 5 to 4 mg twice daily, and the duration of treatment was from one to 30 days.
There were two litters in the original experiments where the mothers were both treated, but only half the pups from each litter were given further treatment. Results in these two litters are therefore recorded in both groups 1 and 2, according to whether the pups concerned were exposed to pentagastrin postnatally or not. Group 3 This consisted of six control litters, where neither the mother nor the pups were treated. Group 4 This was a group in which the four mothers were treated with the depot vehicle only. Two were given injections of beeswax, and the other two gelatin.
There was thus considerable variation in the dosage and duration of treatment given to different animals even without taking into account the weight differences between them (Table 1) . Details of the treatment given to individual animals are recorded elsewhere (Dodge, 1970; Karim, 1975 The incidence of pyloric muscle hypertrophy, and of puppies revealed 16 instances of pyloric hypertrophy pyloroduodenal ulceration, is given in Table 1 . The -that is, 291 %. Nine of the 56 pups had ulcers in relative incidence of these lesions between the four the pre-pyloric region, pyloric canal, or duodenum groups is summarized in Table 2 . The gross ap-at necropsy (163 %), and in three instances perforapearances of the pylorus in affected pups varied tion occurred. It was noted on occasion that, within from definite thickening to typical tumours similar individual litters, some pups had pyloric hyperto those seen in human infants (Fig. 1) . There were eight bitches in group 2 whose 35 puppies were treated with depot pentagastrin injections. Nine of the pups had pyloric hypertrophy at necropsy (25 7%) and five had ulcers (143 %). The ulcers were situated in the pylorus in two, in the duodenum in three, and one of the latter died from perforation of a concomitant oesophageal ulcer. In spite of the continued administration of pentagastrin daily for varying periods to the puppies, the incidence of ulceration was slightly lower in this group than in group 1, but the difference was not statistically significant. Three of the nine with hypertrophy also had ulceration.
GROUP 3
None of the six bitches or their 29 offspring in this group received any form of injection, and none showed any abnormalities on postmortem examination. GROUP 4 In the four instances where bitches were treated with injections of beeswax or gelatin without pentagastrin, no abnormalities of the digestive tract were found in either the mothers or their 18 offspring.
The histological features of the pylorus in pups showing hypertrophy closely resembled those of the human infant with pyloric stenosis. The circular muscle was hypertrophic (Fig. 2) . Ganglion cells in the myenteric plexus showed changes in size and configuration compared with normals, and occasional vacuolation was present. Submucosal ganglion cells were absent at the pyloroduodenal junction.
Statistical analysis showed that the control groups differed significantly (p < 0 01) from groups 1 and 2 in respect of the incidence of both pyloric hypertrophy and ulceration. No correlation was found between the incidence of pyloric hypertrophy and either the absolute or weight-related dose of Pentagastrin given to mothers, nor did the duration of treatment appear to be directly related to the presence of pathological changes. No significant differences were found when the two pentagastrin preparations were compared for incidence of hypertrophy or ulcers, and there was no significant difference between the groups treated with beeswax and gelatin-based preparations in respect of dosage of Pentagastrin or duration of treatment (p < 010 using Fisher's exact probability test).
Discussion
Gastrin has been shown to cross the placenta in dogs (Bruckner et al., 1970) . In the human infant, there is evidence that secretion of gastrin is already established at birth, but it remains to be demonstrated that gastrin secretion occurs in utero or that maternal gastrin crosses the placenta (Rogers et al., 1974) .
A preliminary report that administration of pentagastrin to pregnant bitches may produce hypertrophic pyloric stenosis and gastroduodenal ulceration in their offspring (Dodge, 1970) (Karim, 1975) and will be the subject of further reports. The ganglion cell changes seen in human infantile pyloric stenosis in this study, and in affected puppies, closely resembled previous descriptions of the human disorder (Alarotu, 1956 ). The exact mechanism by which the characteristic hypertrophy is brought about is still uncertain.
Pentagastrin is believed to have direct somatotrophic properties (Johnson et al., 1969) and, in addition, it is a potent stimulant of antral motility (Misiewicz et al., 1969) . It has recently been suggested that the acid secretagogue effect of pentagastrin may in turn stimulate the release of secretin and cholecystokinin, and that it is these hormones which mainly induce contraction and ultimately hypertrophy in the pylorus (Rogers et al., 1975) . The fact that pyloroduodenal ulceration also occurred in some of the animals was not surprising, in view of the finding of duodenal ulcers in cats subjected to stimulation with gastrin (Emas and Grossman, 1967) . It is noteworthy that there is no correlation between pyloric hypertrophy and ulceration in individual animals. However, the occasional occurrence of both infantile pyloric stenosis and duodenal ulcer in the same babies has been recorded (Scharli et al., 1969) .
In spite of the inconsistency of response, transplacental pentagastrin stimulation of the canine fetus appears to be a valid animal model for infantile pyloric stenosis. 
